Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pfizer COVID-19 vaccine efficacy drops to 84% after 6 months, preprint study suggests By: FOXNews.com July 28, 2021 at 15:13 PM EDT A new study involving the Pfizer-BioNTech COVID-19 vaccine suggests the jab’s efficacy drops to around 84% about six months after the second dose. Read More >> Related Stocks: Fancamp Exploration Ltd Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Pfizer COVID-19 vaccine efficacy drops to 84% after 6 months, preprint study suggests By: FOXNews.com July 28, 2021 at 15:13 PM EDT A new study involving the Pfizer-BioNTech COVID-19 vaccine suggests the jab’s efficacy drops to around 84% about six months after the second dose. Read More >> Related Stocks: Fancamp Exploration Ltd